Pages that link to "Q48473495"
Jump to navigation
Jump to search
The following pages link to Chronic intermittent hypoxia predisposes to liver injury (Q48473495):
Displaying 50 items.
- Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1 (Q21562727) (← links)
- Obstructive sleep apnea syndrome and fatty liver: Association or causal link? (Q24612841) (← links)
- Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus (Q26778430) (← links)
- The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease (Q26780509) (← links)
- Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease (Q26827665) (← links)
- Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions (Q28079432) (← links)
- The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms (Q28390983) (← links)
- Effects of various degrees of oxidative stress induced by intermittent hypoxia in rat myocardial tissues (Q28574385) (← links)
- Association of diethylhexyl phthalate with obesity-related markers and body mass change from birth to 3 months of age (Q29109840) (← links)
- Pathophysiology of sleep apnea (Q30440658) (← links)
- SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS (Q30494316) (← links)
- Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin (Q33418684) (← links)
- Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease (Q33583409) (← links)
- An experimental research on chronic intermittent hypoxia leading to liver injury (Q33617925) (← links)
- Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice (Q33781383) (← links)
- Acute exposure to ozone exacerbates acetaminophen-induced liver injury in mice (Q33792450) (← links)
- Chronic permanent hypoxemia predisposes to mild elevation of liver stiffness (Q34036780) (← links)
- Metabolic consequences of intermittent hypoxia: Relevance to obstructive sleep apnea (Q34447691) (← links)
- Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism (Q34598057) (← links)
- Reduction of oxidative stress attenuates lipoapoptosis exacerbated by hypoxia in human hepatocytes (Q35139035) (← links)
- Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease (Q35157250) (← links)
- Uncoupling protein-2 mRNA expression in mice subjected to intermittent hypoxia (Q35597819) (← links)
- Intermittent Hypoxia Exacerbates Metabolic Effects of Diet‐Induced Obesity (Q35702905) (← links)
- Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology (Q35843452) (← links)
- Intermittent Hypoxia Alters Gene Expression in Peripheral Blood Mononuclear Cells of Healthy Volunteers (Q35866630) (← links)
- Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease (Q35870004) (← links)
- Investigation of acetone, butanol and carbon dioxide as new breath biomarkers for convenient and noninvasive diagnosis of obstructive sleep apnea syndrome (Q36019458) (← links)
- Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea (Q36076679) (← links)
- Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease (Q36234613) (← links)
- Obstructive sleep apnea with excessive daytime sleepiness is associated with non-alcoholic fatty liver disease regardless of visceral fat. (Q36272098) (← links)
- Inflammation induced by increased frequency of intermittent hypoxia is attenuated by tempol administration (Q36322301) (← links)
- Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? (Q36323458) (← links)
- 2,3-Oxidosqualene cyclase protects liver cells from the injury of intermittent hypoxia by regulating lipid metabolism (Q36327858) (← links)
- Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver (Q36443187) (← links)
- Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? (Q36520139) (← links)
- Sleep Apnea and Fatty Liver Are Coupled Via Energy Metabolism (Q36722365) (← links)
- Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea (Q36752050) (← links)
- Animal models of sleep disorders (Q36761993) (← links)
- Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease (Q36921610) (← links)
- Intermittent hypoxia has organ-specific effects on oxidative stress (Q36956636) (← links)
- Risk factors and mechanisms of non-alcoholic steatohepatitis (Q37009739) (← links)
- Pediatric obstructive sleep apnea: complications, management, and long-term outcomes (Q37077182) (← links)
- Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity (Q37077790) (← links)
- Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia (Q37264664) (← links)
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression (Q37280624) (← links)
- Adiponectin protects the rats liver against chronic intermittent hypoxia induced injury through AMP-activated protein kinase pathway (Q37291332) (← links)
- Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease (Q37417026) (← links)
- Metabolic consequences of sleep-disordered breathing (Q37511434) (← links)
- Hypoxia and Hypoxia Inducible Factors: Diverse Roles in Liver Diseases (Q37961603) (← links)
- Metabolic syndrome and risk factors for non-alcoholic fatty liver disease (Q38000540) (← links)